Charles Atkinson

Array ( [id] => 1282703 [patent_doc_number] => 06638500 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Polyol-IFN-conjugates modified at Cys-17 and composition containing same' [patent_app_type] => B1 [patent_app_number] => 09/698133 [patent_app_country] => US [patent_app_date] => 2000-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 6618 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638500.pdf [firstpage_image] =>[orig_patent_app_number] => 09698133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1139800 [patent_doc_number] => 06780979 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-24 [patent_title] => 'Method for purifying PrPres from a biological sample and applications' [patent_app_type] => B1 [patent_app_number] => 09/622421 [patent_app_country] => US [patent_app_date] => 2000-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 5384 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780979.pdf [firstpage_image] =>[orig_patent_app_number] => 09622421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261128 [patent_doc_number] => 06664069 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Use of GABAB receptor agonists in the screening of compounds which are reflux inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/658242 [patent_app_country] => US [patent_app_date] => 2000-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3491 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664069.pdf [firstpage_image] =>[orig_patent_app_number] => 09658242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 682763 [patent_doc_number] => 07081519 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-25 [patent_title] => 'Antibodies to serine protease polypeptides' [patent_app_type] => utility [patent_app_number] => 09/658677 [patent_app_country] => US [patent_app_date] => 2000-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11342 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/081/07081519.pdf [firstpage_image] =>[orig_patent_app_number] => 09658677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056272 [patent_doc_number] => 06855495 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-15 [patent_title] => 'Toso as a target for drug screening' [patent_app_type] => utility [patent_app_number] => 09/651150 [patent_app_country] => US [patent_app_date] => 2000-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 24 [patent_no_of_words] => 21898 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855495.pdf [firstpage_image] =>[orig_patent_app_number] => 09651150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391821 [patent_doc_number] => 06531122 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => 'Interferon- variants and conjugates' [patent_app_type] => B1 [patent_app_number] => 09/648569 [patent_app_country] => US [patent_app_date] => 2000-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 35050 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531122.pdf [firstpage_image] =>[orig_patent_app_number] => 09648569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1202086 [patent_doc_number] => 06719969 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-13 [patent_title] => 'Treatment of liver disease and injury with CXC chemokines' [patent_app_type] => B1 [patent_app_number] => 09/632531 [patent_app_country] => US [patent_app_date] => 2000-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 31 [patent_no_of_words] => 50057 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/719/06719969.pdf [firstpage_image] =>[orig_patent_app_number] => 09632531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4302279 [patent_doc_number] => 06326168 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Brain specific potassium channel protein' [patent_app_type] => 1 [patent_app_number] => 9/600776 [patent_app_country] => US [patent_app_date] => 2000-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 17788 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326168.pdf [firstpage_image] =>[orig_patent_app_number] => 600776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391813 [patent_doc_number] => 06544946 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Inhibitors for use in hemostasis and immune function' [patent_app_type] => B1 [patent_app_number] => 09/619740 [patent_app_country] => US [patent_app_date] => 2000-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 24062 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544946.pdf [firstpage_image] =>[orig_patent_app_number] => 09619740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261162 [patent_doc_number] => 06664077 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'DNA encoding ACPL' [patent_app_type] => B1 [patent_app_number] => 09/616530 [patent_app_country] => US [patent_app_date] => 2000-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29345 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664077.pdf [firstpage_image] =>[orig_patent_app_number] => 09616530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1247975 [patent_doc_number] => 06673555 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Methods of using SCAP antagonists' [patent_app_type] => B1 [patent_app_number] => 09/615095 [patent_app_country] => US [patent_app_date] => 2000-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 12971 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673555.pdf [firstpage_image] =>[orig_patent_app_number] => 09615095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1234467 [patent_doc_number] => 06689353 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Stabilized interleukin 2' [patent_app_type] => B1 [patent_app_number] => 09/605577 [patent_app_country] => US [patent_app_date] => 2000-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4157 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689353.pdf [firstpage_image] =>[orig_patent_app_number] => 09605577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1020820 [patent_doc_number] => 06887461 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Method of using IL-11 for treating mucositis' [patent_app_type] => utility [patent_app_number] => 09/604378 [patent_app_country] => US [patent_app_date] => 2000-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8466 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887461.pdf [firstpage_image] =>[orig_patent_app_number] => 09604378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459027 [patent_doc_number] => 06426329 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-30 [patent_title] => 'Immunosuppressant activity of insulin-like growth factor I (IGF-I)' [patent_app_type] => B1 [patent_app_number] => 09/581236 [patent_app_country] => US [patent_app_date] => 2000-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5237 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/426/06426329.pdf [firstpage_image] =>[orig_patent_app_number] => 09581236 [rel_patent_id] =>[rel_patent_doc_number] =>)